Christopher Durant Turner Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 weeks ago
Christopher Durant Turner has an estimated net worth of at least $10.1 million*, as of April 22, 2026. They own 72,630 shares of NUVL stock. They have sold 34,993 shares of NUVL stock since 2021, for an estimated $2.2 million.
Christopher Durant Turner $NUVL SEC Form 4 Insider Trading
Christopher Durant Turner has filed a total of 21 insider trades in $NUVL since 2021. Their most recent trade was a sale of 225 shares, made on Jan 06, 2026. Their largest trade was a sale of 10,235 shares, made on Jun 05, 2023. We estimate that they now own 72,630 shares of $NUVL, worth an estimated $7.9 million.
Insider Trading at $NUVL
There have been a total of 544 insider trades reported at $NUVL since 2021, with 1.5 million shares purchased and 7.3 million shares sold. The most active insider traders in $NUVL stock have been Darlene Noci, Deborah Ann Miller, and Alexandra Balcom. The most recent trade was a sale of 1,699 shares reported by James Richard Porter (President and CEO), made on May 04, 2026.
History of Insider Stock Trades by Christopher Durant Turner
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NUVL
|
Sale | 225 | Jan 06, 2026 | Jan. 7, 2026, 6:26 p.m. |
|
NUVL
|
Sale | 317 | Jan 05, 2026 | Jan. 7, 2026, 6:26 p.m. |
|
NUVL
|
Sale | 1,321 | Jan 06, 2026 | Jan. 7, 2026, 6:26 p.m. |
|
NUVL
|
Sale | 1,635 | Jan 06, 2026 | Jan. 7, 2026, 6:26 p.m. |
|
NUVL
|
Sale | 871 | Jan 05, 2026 | Jan. 7, 2026, 6:26 p.m. |
|
NUVL
|
Sale | 1,119 | Jan 05, 2026 | Jan. 7, 2026, 6:26 p.m. |
|
NUVL
|
Sale | 1,929 | Jan 05, 2026 | Jan. 7, 2026, 6:26 p.m. |
|
NUVL
|
Sale | 2,173 | Jan 06, 2025 | Jan. 8, 2025, 5:50 p.m. |
|
NUVL
|
Sale | 691 | Jan 06, 2025 | Jan. 8, 2025, 5:50 p.m. |
|
NUVL
|
Sale | 1,152 | Jan 06, 2025 | Jan. 8, 2025, 5:50 p.m. |
|
NUVL
|
Sale | 600 | Oct 04, 2023 | Oct. 6, 2023, 4:58 p.m. |
|
NUVL
|
Sale | 500 | Oct 04, 2023 | Oct. 6, 2023, 4:58 p.m. |
|
NUVL
|
Sale | 1,465 | Oct 04, 2023 | Oct. 6, 2023, 4:58 p.m. |
|
NUVL
|
Sale | 500 | Oct 04, 2023 | Oct. 6, 2023, 4:58 p.m. |
|
NUVL
|
Sale | 2,665 | Oct 04, 2023 | Oct. 6, 2023, 4:58 p.m. |
|
NUVL
|
Sale | 2,265 | Oct 04, 2023 | Oct. 6, 2023, 4:58 p.m. |
|
NUVL
|
Sale | 2,365 | Jul 26, 2023 | July 28, 2023, 4:51 p.m. |
|
NUVL
|
Sale | 2,665 | Jul 28, 2023 | July 28, 2023, 4:51 p.m. |
|
NUVL
|
Sale | 100 | Jul 20, 2023 | July 24, 2023, 4:54 p.m. |
|
NUVL
|
Sale | 200 | Jul 24, 2023 | July 24, 2023, 4:54 p.m. |
|
NUVL
|
Sale | 10,235 | Jun 05, 2023 | June 7, 2023, 4:50 p.m. |
$NUVL Executives and Stock Owners with Insider Trades
-
Darlene Noci, Chief Development Officer
-
Deborah Ann Miller, Chief Legal Officer
-
Alexandra Balcom, Chief Financial Officer
-
James Richard Porter, President and CEO
-
Henry E. Pelish, Chief Scientific Officer
-
Christopher Durant Turner, Chief Medical Officer
-
Darlene Noci, See Remarks
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.